Everyone and all media talking about clinical trials

I watch the media discussions on the effectiveness of the new vaccine candidate with incredulous astonishment. Vaccinations started more or less quickly in various countries. The hope for more new vaccines with simplified handling is realistic. The hope of normalization is in the air, the lockdown is costing the economies enormous sums of money and now this:

An tremedous interest in the details of clinical studies carried out, the data for drug approvals and the calculations for the effectiveness of vaccinations. The different approaches mRNA vaccination and vector-based vaccination are included.

The development times of the new corona vaccines beats everything that has come before! 10 months and the goal is within reach. What news of success! Critical voices are now increasing: the cohorts of the study participants were not chosen representative, the phases were run in parallel, the dosages were not constant, there was a pause in a study. How for heaven's sake is it even approved?

I'm excited! Not only from the scientific details, which are in fact not always clear, but from the interest of the mass media and the masses in the subject of “clinical studies” and “drug development”. Broad sections of the population, from schoolchildren and adolescents, students of all subjects, to adults of all professional groups, to pensioners and vaccinated people. Everyone reads into the details of drug development. Numerous videos of interviews and talk shows with experts are circulating on the net. Epidemiologists, virologists, pharmacologists, doctors, statisticians explain, clarify, correct, speculate. A real scientific people information campaign. Cheers to this new and broad interest in the applied natural sciences and thus the pharmaceutical industry!

I hope that this will continue and that we will continue to critically observe new developments in biochemistry, molecular biology and immunology, inform ourselves and also comment on them. That we become aware of the inconsistencies in scientific data and test series, that we can perhaps guess at the expense of such a development and that we regard the new drugs as what they have always been: Knight in shining armor! But not free from risks and side effects.